Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Pezzutto, Antonio Prof. Dr. (2) Walther, Wolfgang Prof. Dr. (1) Willimsky, Gerald Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (17) (-) Molekulare Immunologie und Gentherapie (17) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) (-) 1995 (8) 1996 (6) (-) 1997 (9) 1998 (9) 1999 (4) 2000 (8) 2001 (8) 2002 (8) 2003 (10) 2004 (10) 2005 (14) 2006 (3) 2007 (6) 2008 (8) 2009 (8) 2010 (10) 2011 (12) 2012 (10) 2013 (15) 2014 (15) 2015 (13) 2016 (12) 2017 (12) 2018 (10) 2019 (11) 2020 (6) 2021 (16) 2022 (16) 2023 (9) 2024 (2) 17 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Molekulare Immunologie und Gentherapie 19951997 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. Oktober 1997 / J Immunol Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis P.T. Daniel A. Kroidl S. Cayeux R.C. Bargou T. Blankenstein B. Doerken 15. Juli 1997 / J Immunol Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte- macrophage colony-stimulating factor gene-modified tumor cells Z. Qin G. Noffz M. Mohaupt T. Blankenstein 01. Januar 1995 / Cytokine The rat interleukin-4 receptor: coevolution of ligand and receptor G. Richter G. Hein T. Blankenstein T. Diamantstein 01. Januar 1995 / Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein 01. Januar 1995 / J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling 01. Januar 1997 / Eur J Immunol Lack of correlation between rejection of tumor cells co-expressing interleukin 2 and B7.1 and vaccine efficiency S. Cayeux G. Richter C. Becker C. Beck A. Aicher A. Pezzutto B. Doerken T. Blankenstein 01. Januar 1995 / Eur J Immunol Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines S. Cayeux C. Beck A. Aicher B. Doerken T. Blankenstein 01. Januar 1995 / Eur J Cancer European school of oncology position paper - gene therapy for the medical oncologist M. Blaese T. Blankenstein M. Brenner O. Cohenhaguenauer B. Gansbacher B. Sorrentino T. Velu 01. Januar 1995 / Hum Gene Ther The thymidine kinase/ganciclovir-mediated "suicide" effect is highly variable in different tumor cells C. Beck S. Cayeux S. Lupton B. Doerken T. Blankenstein 01. Januar 1995 / Canc Res Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response Z. Qin T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
15. Oktober 1997 / J Immunol Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis P.T. Daniel A. Kroidl S. Cayeux R.C. Bargou T. Blankenstein B. Doerken
15. Juli 1997 / J Immunol Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte- macrophage colony-stimulating factor gene-modified tumor cells Z. Qin G. Noffz M. Mohaupt T. Blankenstein
01. Januar 1995 / Cytokine The rat interleukin-4 receptor: coevolution of ligand and receptor G. Richter G. Hein T. Blankenstein T. Diamantstein
01. Januar 1995 / Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein
01. Januar 1995 / J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling
01. Januar 1997 / Eur J Immunol Lack of correlation between rejection of tumor cells co-expressing interleukin 2 and B7.1 and vaccine efficiency S. Cayeux G. Richter C. Becker C. Beck A. Aicher A. Pezzutto B. Doerken T. Blankenstein
01. Januar 1995 / Eur J Immunol Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines S. Cayeux C. Beck A. Aicher B. Doerken T. Blankenstein
01. Januar 1995 / Eur J Cancer European school of oncology position paper - gene therapy for the medical oncologist M. Blaese T. Blankenstein M. Brenner O. Cohenhaguenauer B. Gansbacher B. Sorrentino T. Velu
01. Januar 1995 / Hum Gene Ther The thymidine kinase/ganciclovir-mediated "suicide" effect is highly variable in different tumor cells C. Beck S. Cayeux S. Lupton B. Doerken T. Blankenstein
01. Januar 1995 / Canc Res Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response Z. Qin T. Blankenstein